Therapy Areas: Infectious Diseases
Ender Diagnostics Receives FDA Notification for Rapid and Reliable COVID-19 Tests
24 November 2020 - - The two COVID-19 tests from Switzerland-based Ender Diagnostics have received FDA approval, marking the entry of the Swiss company into the US market, the company said.

Appili Therapeutics Starts New Phase 3 Clinical Trial to Evaluate Avigan Tablets in the Prevention of COVID-19
24 November 2020 - - Canada-based biopharmaceutical company Appili Therapeutics Inc. (TSX: APLI) (OTCQX: APLIF) has initiated its Phase 3 Post Exposure Prophylaxis for COVID-19 (PE...
ReiThera provides update on Phase 1 study of vaccine candidate GRAd-COV2
24 November 2020 - Biotechnology company ReiThera Srl reported on Tuesday that its ongoing Phase 1 study of its vaccine candidate (GRAd-COV2) against the novel coronavirus (SARS-CoV-2) is advancing on...
VBI Vaccines Submits Marketing Authorization Application for 3-Antigen Prophylactic Hepatitis B Vaccine to the European Medicines Agency
24 November 2020 - - US-based biopharmaceutical company VBI Vaccines Inc. (NASDAQ: VBIV) has submitted a Marketing Authorization Application to the European Medicines Agency for the company's 3-a...
Twist Bioscience Tout Positive Preclinical Data for SARS-CoV-2 Antibodies
23 November 2020 - - US-based synthetic biology and genomics company Twist Bioscience Corp. (NASDAQ: TWST) has released preclinical data for three of its proprietary antibodies against the S1 protein ...
AbCellera's Bamlanivimab authorized to treat new mild to moderate COVID-19 in high-risk patients
23 November 2020 - Antibody discovery company AbCellera revealed on Friday that its human antibody bamlanivimab (LY-CoV555) in 700 mg, developed through its collaboration with Eli Lilly and Company, h...
Related Headlines

FDA Grants Emergency Use Authorisation for Baricitinib in Hospitalised COVID-19

AbCellera-Discovered Antibody Granted Interim Authorization by Health Canada as a Treatment for COVID-19

First Patient in Phase 2 Outpatient Study of Brequinar to Treat COVID-19

Eli Lilly and Company & Incyte partnership announces FDA's EUA for use of baricitinib in combination with remdesivir in hospitalized adult and pediatric COVID-19 patients

Phoenix Biotechnology Inc announces Oleandrin's antiviral activity against SARS-CoV-2

Colgate Laboratory's tests show toothpaste and mouthwash neutralize 99.9% of SARS-CoV-2

VBI Vaccines Touts Positive Interim Phase 1b/2a Data for Hepatitis B Immunotherapeutic in Patients with Chronic Infection

CreaGen Awarded 7-Year Contract from NIH's National Institute of Allergy and Infectious Diseases (NIAID) to Provide Preclinical Services for HIV Therapeutics

FDA Authorizes First Prescription at Home Molecular Test for COVID-19

Moderna Inc announces EMA's rolling review process of mRNA-1273 vaccine against COVID-19

Preliminary trial results of Sinovac's COVID-19 vaccine shows induced quick immune response

Moderna Inks Supply Agreement with United Kingdom government to Supply mRNA Vaccine Against COVID-19 if Approved for Use

HealthCore Coordinating First US Longitudinal Study to Understand New COVID-19 Pediatric Syndrome with Greater Impact on Black and Latino Children

Mycovia Pharmaceuticals Completes Successful Pre-NDA Meeting with FDA for Oteseconazole for the Treatment of Recurrent Vulvovaginal Candidiasis

First Patient Dosed in Phase 1 Clinical Study of SLV213, a Potential Oral Treatment for COVID-19